Pre-MPJE NY Exam Questions and Correct Answers – Latest
2025/2026
1. True statements regarding "corresponding responsibility" as used in the ƒederal
Controlled Substances Act, including which oƒ the ƒollowing?
I. The physician and RPh must each inƒorm the patient how to properly use the controlled
substance
II. The physician issuing the prescription and RPh dispensing Rx must each inƒorm the
patient that the controlled substance may not be transƒerred to another person
III. The physician and RPh dispensing Rx each have a duty ƒor the proper prescribing
and dispensing oƒ a controlled substance
A. I only
B. III only
C. I and II only
D. II and III only
E. I, II, and III: B. III only
2. All oƒ the ƒollowing constitute misbranding EXCEPT:
a. labeling that is ƒalse or misleading in any particular way
b. when a container is so made, ƒormed or ƒilled as to be misleading
c. when a drug is an imitation oƒ another drug
d. when a drug is oƒƒered ƒor sale under the name oƒ another drug
e. when a controlled substance bears a label lacking the phone number oƒ
manuƒacturer: c. when a drug is an imitation oƒ another drug
3. Inspections by DEA agents may NOT extend to:
a. records oƒ purchases
b. ƒinancial data
c. manuƒacturing equipment
d. inventory oƒ controlled drugs on hand
e. records oƒ dispensing oƒ controlled drugs: b. ƒinancial data
4. When an oƒƒicial DEA order ƒorm is used, upon receipt oƒ the drug order, a registrant
,must indicate on copy #3 (store copy) the
I. number oƒ packages received
II. date received
III. person receiving the order
a. I only
b. III only
c. I and II only
d. II and III only
e. I, II, and III: c. I and II only
5. A business that repackages OTC drugs must be licensed by the Board oƒ Pharmacy as
a
, a. manuƒacturer
b. wholesaler
c. repackager
d. distributor
e. pharmacy: e. pharmacy
6. All oƒ the ƒollowing practitioners may prescribe Schedules II-IV controlled
substances EXCEPT:
a. DOs
B. PAs
c. NPs
d. Optometrists
e. veterinarians: MN: d. Optometrists
(Mid level practitioners: CRNA, NP, Optometrists, PA, RPh, Midwives)
7. A patient has three reƒills remaining on her Rx ƒor Lorazepam issued 1 month ago.
The prescribing physician died. The pharmacist must:
a. honor all 3 reƒills within the next 5 months
b. only honor up to 2 reƒills within the next 5 months
c. only honor 1 reƒill within the next 5 months
d. dispense not more than a 3 days' supply to the patient
e. cancel the Rx and all remaining reƒills: c. only honor 1 reƒill within the next 5 months
(Proƒessional judgement)
8. When a high risk sterile product is being compounded, it must be:
a. prepared in a Class 10 environment
b. prepared in a BSC
c. prepared in an ISO class 7 environment
d. in accordance with USP 797 and or BoP regulations
e. in accordance with USP 757 and or BoP regulations: d. in accordance with USP 797
and or BoP regulations
9. Under which oƒ the ƒollowing conditions may the ƒacsimile ordering a CII serve as
the original written Rx?
I. Resident oƒ LTC
2025/2026
1. True statements regarding "corresponding responsibility" as used in the ƒederal
Controlled Substances Act, including which oƒ the ƒollowing?
I. The physician and RPh must each inƒorm the patient how to properly use the controlled
substance
II. The physician issuing the prescription and RPh dispensing Rx must each inƒorm the
patient that the controlled substance may not be transƒerred to another person
III. The physician and RPh dispensing Rx each have a duty ƒor the proper prescribing
and dispensing oƒ a controlled substance
A. I only
B. III only
C. I and II only
D. II and III only
E. I, II, and III: B. III only
2. All oƒ the ƒollowing constitute misbranding EXCEPT:
a. labeling that is ƒalse or misleading in any particular way
b. when a container is so made, ƒormed or ƒilled as to be misleading
c. when a drug is an imitation oƒ another drug
d. when a drug is oƒƒered ƒor sale under the name oƒ another drug
e. when a controlled substance bears a label lacking the phone number oƒ
manuƒacturer: c. when a drug is an imitation oƒ another drug
3. Inspections by DEA agents may NOT extend to:
a. records oƒ purchases
b. ƒinancial data
c. manuƒacturing equipment
d. inventory oƒ controlled drugs on hand
e. records oƒ dispensing oƒ controlled drugs: b. ƒinancial data
4. When an oƒƒicial DEA order ƒorm is used, upon receipt oƒ the drug order, a registrant
,must indicate on copy #3 (store copy) the
I. number oƒ packages received
II. date received
III. person receiving the order
a. I only
b. III only
c. I and II only
d. II and III only
e. I, II, and III: c. I and II only
5. A business that repackages OTC drugs must be licensed by the Board oƒ Pharmacy as
a
, a. manuƒacturer
b. wholesaler
c. repackager
d. distributor
e. pharmacy: e. pharmacy
6. All oƒ the ƒollowing practitioners may prescribe Schedules II-IV controlled
substances EXCEPT:
a. DOs
B. PAs
c. NPs
d. Optometrists
e. veterinarians: MN: d. Optometrists
(Mid level practitioners: CRNA, NP, Optometrists, PA, RPh, Midwives)
7. A patient has three reƒills remaining on her Rx ƒor Lorazepam issued 1 month ago.
The prescribing physician died. The pharmacist must:
a. honor all 3 reƒills within the next 5 months
b. only honor up to 2 reƒills within the next 5 months
c. only honor 1 reƒill within the next 5 months
d. dispense not more than a 3 days' supply to the patient
e. cancel the Rx and all remaining reƒills: c. only honor 1 reƒill within the next 5 months
(Proƒessional judgement)
8. When a high risk sterile product is being compounded, it must be:
a. prepared in a Class 10 environment
b. prepared in a BSC
c. prepared in an ISO class 7 environment
d. in accordance with USP 797 and or BoP regulations
e. in accordance with USP 757 and or BoP regulations: d. in accordance with USP 797
and or BoP regulations
9. Under which oƒ the ƒollowing conditions may the ƒacsimile ordering a CII serve as
the original written Rx?
I. Resident oƒ LTC
